Psychedelics, particularly psilocybin and MDMA, may be a useful tool in combatting prolonged grief disorder, according to a new study conducted by researchers from Johns Hopkins University School of Medicine and the University of Virginia.

Dried psilocybin (left), and MDMA tablets (right).
“Prolonged Grief Disorder (PGD) is distinct from yet related to non-pathologic grief, depression, addiction, and Post-Traumatic Stress Disorder (PTSD) with a prevalence of up to 10% in bereaved populations”, states the study, published by the journal International Review of Psychiatry.
The study states that “Hallmarks of PGD include functional impairment a year or more post-bereavement and intense yearning for the deceased. Current treatments for PGD are typically psychological rather than psychopharmacological, and more treatment options are needed.”
Continue reading